Blog Post

ATAGI recommendation for COVID Vaccination in immunocompromised patients

8 Oct 2021 4:52 PM | HSANZ Office (Administrator)

Dear Colleagues, re: The ATAGI recommendation for COVID Vaccination in immunocompromised patients

This is an important recommendation from ATAGI and is relevant to many patients with haematological disorders who may have reduced response to standard COVID vaccination regimens.
Steven Lane, President HSANZ

Click here for document

OFFICE
145 Macquarie Street,
Sydney NSW 2000
hsanz@hsanz.org.au

CONTACT HSANZ
PRIVACY POLICY